Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06280300 · ClinicalTrials.gov registry record · NA
Multi-disciplinary Care for Brain Metastases
A NA study of Brain Metastases, Adult, sponsored by University of Vermont Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06280300: Recruiting NA study of Brain Metastases, Adult, sponsored by University of Vermont Medical Center.
NCT06280300 is a NA study of Brain Metastases, Adult that is actively recruiting participants, run by University of Vermont Medical Center. The registered enrollment target is 40 participants, below the 94-participant average among 14 other Brain Metastases, Adult trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06280300, a NA study of Brain Metastases, Adult, is actively recruiting participants, sponsored by University of Vermont Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a health services intervention study aimed at understanding the impact of intensive multi-disciplinary care compared with standard care on patient-reported symptom outcomes and prognostic awareness in patients with brain metastases.
Primary Outcome
Symptom burden based on patient reporting on Brain Mets Symptom Inventory
Conditions Studied
Interventions
- OTHER health services intervention
Study Locations (1)
Vermont
- University of Vermont Medical Center - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-11-16 |
| Est. Completion | 2027-07-01 |
| Phase | NA |
What NCT06280300 shows while recruiting
NCT06280300 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 94-participant average among 14 other Brain Metastases, Adult trials with a reported enrollment target (57% lower).
The record links to 1 condition, with Brain Metastases, Adult appearing as the primary indexed condition, and to 1 intervention - of which health services intervention is the first listed.
NCT06280300 reports a single indexed study location in Vermont.
Frequently Asked Questions
What is clinical trial NCT06280300 about?
NCT06280300 is a clinical study titled "Multi-disciplinary Care for Brain Metastases". This is a health services intervention study aimed at understanding the impact of intensive multi-disciplinary care compared with standard care on patient-reported symptom outcomes and prognostic awareness in patients with brain metastases.
What is the current status of trial NCT06280300?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-11-16. Estimated completion is 2027-07-01.
What conditions does trial NCT06280300 study?
This clinical trial studies the following conditions: Brain Metastases, Adult.
What interventions are being tested in trial NCT06280300?
The interventions under investigation include: health services intervention (OTHER).
Who is sponsoring clinical trial NCT06280300?
This trial is sponsored by University of Vermont Medical Center, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06280300 being conducted?
This trial has 1 study location across Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Metastases, Adult
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06280300's enrollment target sits among peer trials
40 12th of 14 higher than 3 of 14 other Brain Metastases, Adult trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Metastases, Adult trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy
RECRUITING · NA
-
A Phase II Study of Pre-Op SRS Followed by Surgical Resection for Brain Metastases
ACTIVE NOT RECRUITING · NA
-
18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery
RECRUITING · Phase 1
-
Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery
RECRUITING · Phase 1
-
UCSD Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases
RECRUITING · Phase 2
-
Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI